King LM, Sanchez GV, Bartoces M, Hicks A, Fleming-Dutra KE. Antibiotic Therapy Duration in US Adults With Sinusitis. JAMA Intern Med 2018:26 de marzo. [Ref.ID 102480]

Zost SJ, Parkhouse K, Gumina ME, Kim K, Díaz Pérez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains . Proceedings of the National Academy of Sciences of the United States of America 2017:6 de noviembre. [Ref.ID 102123]

Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ 2017;358:j4307. [Ref.ID 102094]

Okano A, Isley NA, Boger DL. Peripheral modifications of [?[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics. Proceedings of the National Academy of Sciences of the United States of America 2017:13 de marzo. [Ref.ID 101615]

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim Y-S, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr M-B, for the MODIFY I and MODIFY II Investigators. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 2017;376:305-17. [Ref.ID 101394]

Anónimo. Malaria drug fails in four patients treated In Britain, clinical report shows. DIA Daily 2017:7. [Ref.ID 101385]

Anónimo. Délamanid et tuberculose pulmonaire multirésistante. Prescrire 2017;37:10. [Ref.ID 101359]

Almendrala A. The success of HIV treatment is increasing the risk of drug-resistance. And the threat is growing.. The Huffington Post 2016:1. [Ref.ID 100995]

Anónimo. Fosfomycin for UTIs. Drug Ther Bull 2016;54:114-7. [Ref.ID 100882]

Anónimo. Ibalizumab shows promising results treating multi-drug-resistant HIV. DIA Daily 2016:4. [Ref.ID 100869]

Sheldon T. Saving antibiotics for when they are really needed: the Dutch example. BMJ 2016;354:i4192. [Ref.ID 100707]

Diacon AH, van der Merwe L, Barnard M, von Groote-Bidlingmaier F, Lange C, García-Basteiro AL, Sevene E, Ballell L, Barros-Aguirre D. ß-lactams against tuberculosis — New trick for an old dog?. N Engl J Med 2016;375:393-4. [Ref.ID 100492]

Owen J. Pay drug companies $1bn for each new antibiotic, says report. BMJ 2016;353:i2863. [Ref.ID 100427]

Anónimo. FDA advisory recommends approval of experimental drug to treat Clostridium difficile. DIA Daily 2016:2. [Ref.ID 100401]

Mayor S. European drug agency recommends limiting colistin use in animals to cut resistance in patients. BMJ 2016;353:i3066. [Ref.ID 100383]

Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File Jr TM, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sánchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA 2016;315:1864-73. [Ref.ID 100224]

Tamma PD, Cosgrove SE. Addressing the appropriateness of outpatient antibiotic prescribing in the United States: an important first step. JAMA 2016;315:1839-41. [Ref.ID 100223]

Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ 2016;352:i939. [Ref.ID 100142]

Al-Wali W, Hughes C. Fosfomycin should not be first line treatment for uncomplicated urinary tract infection. BMJ 2016;352:i413. [Ref.ID 100034]

Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ. Trimethoprim–sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 2016;374:3 de marzo. [Ref.ID 100027]